Drug Name
EligibleStudy sitesMore information
ADI-001 (not yet named)
Adults with IIMBuffalo, NYMore details »
Adicet Therapeutics
716-845-3057
NCT06375993
Anifrolumab (JASMINE)
Ages 18-75 with DM or PM217 sites worldwideMore details »
AstraZeneca »
877-240-9479
NCT06455449
AP01 (not yet named)
Adults with myositis and progressive ILD150+ sites worldwideMore details »
Avalyn Pharma »
MISTPPFStudy@AvalynPharma.com
NCT06329401
AZD0120 (AURORA)
Ages 18-75 with IIM18 sites worldwideMore details »
AstraZeneca »
877-240-9479
NCT07295847
AZD5492
Ages 18-70 with PM or DM37 locations worldwideMore details »
AstraZeneca »
877-240-9479
NCT06916806
Brepocitinib (VALOR)
Adults with DM
(currently not recruiting)More details »
Priovant
212-634-9743
NCT05437263
CABA-201 (CAR T cell therapy)
Ages 6-75 with DM, ASyS, IMNM25 sites in the US and UKMore details »
Cabaletta Bio »
NCT06154252
CD-19-Targeted (CAR T cell therapy)
Adults with refractory DM, PM, IMNM54 sites in US and EuropeMore details »
Bristol Myers Squibb »
855-907-3286
NCT05869955
Dazukibart
Adults with active DM or PM128 sites worldwideMore details »
Pfizer »
800-718-1021
NCT05895786
Descartes-08
Adults with DM or ASyS(currently not recruiting)More details »
Cartesian Therapeutics
Trials@cartesiantx.com
617-231-8085
NCT07391605
Efgartigimod (ALKIVIA)
Adults with IIM(currently not recruiting)More details »
argenx
857-350-4834
NCT05523167
Empasiprubart (Empacific)
Adults with DM(currently not recruiting)More details »
argenx
857-350-4834
NCT06284954
Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
Adults with DM, JDMNIH, Bethesda, MDMore details »
301-496-6664
fastdmsupport@nih.gov
NCT07111065
IVIG
The MIGHT Trial – An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy
Adults age 16 or older with HMGCR autoantibody IMNMBirmingham, Baltimore, Houston, Pittsburgh, SeattleMore details »
Hannah E Howell, MS
205-996-6552
heburns@uabmc.edu
NCT06599697
Nipocalimab (SPIREA)
Adults with IIM(currently not recruiting)More details »
J&J Innovative Medicine
844-434-4210
NCT05379634
NKX019 (allogeneic CAR NK cells targeting CD19)
Ages 18-65 with DM, IMNM, or ASyS10 sites in US
More details »
Nkarta, Inc.
clinicaltrials@nkartatx.com
NCT06733935
Pozelimab and Cemdisiran
Ages 45-75 with sIBMAustin, TXMore details »
Austin Neuromuscular Center
Yessar Hussain, MD
research@austinneuromuscle.com
512-930-0140
NCT06479863
Rapcabtagene Autoleucel (CAR T cell therapy)
Adults with DM, NM, ASyS30 sites worldwideMore details »
Novartis
1-888-669-6682
NCT06665256
RAY121 (RAINBOW Trial)
Ages 18-75 with DM or IMNM67 sites worldwideMore details »
Chugai Pharmaceuticals Co., Ltd
clinical-trials@chugai-pharm.co.jp
NCT06371417
Sirolimus
Adults with inclusion body myositis (IBM)(currently not recruiting)More details »
913-945-9926
NCT04789070